홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
NRIX
#1905
Nurix Therapeutics, Inc. Common stock
15.970
0
+2.70%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+2.70%
월간 변동
-18.42%
6달 변화
+42.46%
년간 변동율
+42.46%
이전 종가
15.550
0
Open
15.970
0
Bid
Ask
Low
15.970
0
High
15.970
0
양
162
마켓
주식
헬스케어
NRIX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
38.91 M
44.74 M
47.27 M
48.89 M
75.89 M
102.84 M
—
Valuation ratios
Enterprise value
1.54 B
1.21 B
521.24 M
249.49 M
1.52 B
1.49 B
4.06 B
Price to earnings ratio
—
—
-3.34
-2.35
-7.46
-5.54
-18.83
Price to sales ratio
—
—
15.59
4.39
26.44
17.45
56.77
Price to cash flow ratio
—
—
3.77
4.15
8.36
5.87
19.16
Price to book ratio
—
—
1.98
1.69
2.74
2.72
4.24
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.11
0.25
0.43
0.4
0.29
0.38
0.44
Return on equity %
0.15
0.34
0.59
0.72
0.37
0.49
0.59
Return on invested capital %
132.86
270.56
403.07
629.36
713.83
923.04
904.34
Gross margin %
100
100
100
100
100
100
400
Operating margin %
364.66
396.26
476.01
201.41
390.52
340.16
2 220.03
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
242.66
393.93
466.93
186.98
354.85
314.9
2 074.93
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.7
4.7
4.51
3.4
6.46
7.02
25.45
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.04
0.07
0.09
0.2
0.11
0.12
0.14
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
3.29
1.5
2.57
2.88
2.95
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
6.36
5.3
9.08
6.84
24.31
Net current asset value per share
—
—
6.55
5.44
9.23
7
25.13
Tangible book value per share
—
—
6.25
3.69
7.85
6.22
21.73
Working capital per share
—
—
5.1
3.84
7.8
6
21.17
Book value per share
—
—
6.25
3.69
7.85
6.22
21.73
뉴스
Nurix Therapeutics Stock Sees RS Rating Jump To 82
Nurix 법률 책임자, NRIX 주식 23만 7천 달러 매도
누릭스 테라퓨틱스 법률 책임자, 7.3만 달러 상당 주식 매도
Nurix Therapeutics CFO Hans van Houte sells $61k in shares
Nurix Therapeutics chief legal officer Ring sells $73k in stock
Nurix Therapeutics CSO, 8,900만원 상당 주식 매도
Nurix Therapeutics CSO Gwenn Hansen sells $81k in shares
Nurix 목표 주가, Stifel, $35로 상향 조정
Stifel raises Nurix stock price target to $35 on bexobrutideg potential
Nurix, Piper Sandler 목표 주가 35달러로 상향 조정
Piper Sandler raises Nurix stock price target to $35 on pivotal trial plans
H.C. Wainwright, Nurix 목표 주가 32달러로 상향 조정